1220PD - Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma
| Autor: | Menzies, A.M., Gonzalez, M., Guminski, A., Nieweg, O., Shannon, K., Thompson, J.F., Kefford, R., Ch'Ng, S., Stretch, J., Spillane, A.J., Lee, J., Lee, H., Kapoor, R., Emmett, L., Rizos, H., Saw, R.P., Scolyer, R.A., Long, G.V. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v432-v432 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|